Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects

[1] Gerich JE(2000)Physiology of glucose homeostasis Diabetes Obes Metab 2 345-350

[2] Perley MJ(1967)Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects J Clin Invest 46 1954-1962

[3] Kipnis DM(1986)Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses J Clin Endocrinol Metab 63 492-498

[4] Nauck MA(1988)Incretin effect due to increased secretion and decreased clearance of insulin in normal humans Diabetes 37 200-203

[5] Homberger E(1979)The incretin concept today Diabetologia 16 75-85

[6] Siegel EG(1993)Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations J Clin Endocrinol Metab 76 912-917

[7] Shuster LT(2003)Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects Regul Pept 114 115-121

[8] Go VLW(1988)Effect of truncated glucagon-like peptide-1 [proglucagon-(78–107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach Endocrinology 123 2009-2013

[9] Rizza RA(1993)Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients Diabetologia 36 741-744

[10] O’Brien PC(1978)Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secreton from the perfused rat pancreas Endocrinology 103 610-615

[1] Gerich JE(2000)Physiology of glucose homeostasis Diabetes Obes Metab 2 345-350

[2] Perley MJ(1967)Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects J Clin Invest 46 1954-1962

[3] Kipnis DM(1986)Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses J Clin Endocrinol Metab 63 492-498

[4] Nauck MA(1988)Incretin effect due to increased secretion and decreased clearance of insulin in normal humans Diabetes 37 200-203

[5] Homberger E(1979)The incretin concept today Diabetologia 16 75-85

[6] Siegel EG(1993)Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations J Clin Endocrinol Metab 76 912-917

[7] Shuster LT(2003)Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects Regul Pept 114 115-121

[8] Go VLW(1988)Effect of truncated glucagon-like peptide-1 [proglucagon-(78–107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach Endocrinology 123 2009-2013

[9] Rizza RA(1993)Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients Diabetologia 36 741-744

[10] O’Brien PC(1978)Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secreton from the perfused rat pancreas Endocrinology 103 610-615